Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Geriatric MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Memantine for dementia.Cochrane Database Syst Rev. 2005; : CD003154
- AAFP and ACP release guideline on dementia treatment.Am Fam Physician. 2008; 77: 1173-1175
- Cholinesterase inhibitors for Alzheimer's disease.Cochrane Database Syst Rev. 2006; 2006: CD005593
- The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysis.Int J Geriatr Psychiatry. 2016; 31: 892-904
- The cholinergic hypothesis of geriatric memory dysfunction.Science. 1982; 217: 408-414
- A review of clinical treatment considerations of donepezil in severe Alzheimer's disease.CNS Neurosci Ther. 2018; 24: 876-888
- Long-term effects of cholinesterase inhibitors on cognitive decline and mortality.Neurology. 2021; 96: e2220-e2230
- The overlap between vascular disease and Alzheimer’s disease – lessons from pathology.BMC Med. 2014; 12: 206
- Cholinesterase inhibitors for Lewy Body disorders: a meta-analysis.Int J Neuropsychopharmacol. 2015; 19: pyv086
- Precision medicine for frontotemporal dementia.Front Psychiatry. 2019; 10https://doi.org/10.3389/fpsyt.2019.00075
- Cholinesterase inhibitors for mild cognitive impairment.Cochrane Database Syst Rev. 2012; 2012: CD009132
- Donepezil across the spectrum of Alzheimer’s disease: dose optimization and clinical relevance.Acta Neurol Scand. 2015; 131: 259-267
- Pfizer Inc. Aricept (donepezil hydrochloride) [package insert]. U.S. Food and Drug Administration website.https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020690s035,021720s008,022568s005lbl.pdfDate: 2012Date accessed: August 31, 2022
- Donepezil 23 mg: an empty suit.Neurol Clin Pract. 2012; 2: 352-355
- Donepezil for dementia due to Alzheimer's disease.Cochrane Database Syst Rev. 2018; 6: CD001190
- Novartis. Exelon (rivastigmine tartrate) [package insert]. U.S. Food and Drug Administration website.https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020823s036,021025s024lbl.pdfDate: 2018Date accessed: August 31, 2022
- Rivastigmine for Alzheimer's disease.Cochrane Database Syst Rev. 2015; : CD001191
- An update on the safety of current therapies for Alzheimer's disease: focus on rivastigmine.Ther Adv Drug Saf. 2018; 9: 171-178
- A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease.Prim Care Companion CNS Disord. 2013; 15 (PCC.12r01412)
- Ortho-McNeil Neurologics. Razadyne (galantamine hydrobromide) [package insert]. U.S. Food and Drug Administration website.https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021615s021lbl.pdfDate: 2015Date accessed: August 31, 2022
- Galantamine for Alzheimer's disease and mild cognitive impairment.Cochrane Database Syst Rev. 2006; 2006: CD001747
- Galantamine is not a positive allosteric modulator of human α4β2 or α7 nicotinic acetylcholine receptors.Br J Pharmacol. 2018; 175: 2911-2925
- Safety, pharmacokinetics, and pharmacodynamics of Gln-1062, a prodrug of galantamine.Alzheimers Dement (N Y). 2020; 6: e12093
- Forest Laboratories. Namenda (memantine HCl) [package insert]. U.S. Food and Drug Administration website.https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021487s010s012s014,021627s008lbl.pdfDate: 2013Date accessed: August 31, 2022
- Memantine for dementia.Cochrane Database Syst Rev. 2019; 3: CD003154
- Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer's disease: a network meta-analysis of 41 randomized controlled trials.Alzheimer's Res Ther. 2018; 10: 126
- Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer's disease.Neuropsychiatr Dis Treat. 2014; 10: 391-401
- MMM 500 group. A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500).Int Clin Psychopharmacol. 2002; 17: 297-305
- Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300).Stroke. 2002; 33: 1834-1839
- Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer’s disease: a systematic review and meta-analysis.J Alzhemiers Dis. 2014; 41: 615-631
- Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis.Clin Interv Aging. 2008; 3: 211-225
- Memantine, donepezil, or combination therapy-What is the best therapy for Alzheimer's disease? A network meta-analysis.Brain Behav. 2020; 10: e01831
- Adherence and tolerability of Alzheimer's disease medications: a Pragmatic randomized trial.J Am Geriatr Soc. 2017; 65: 1497-1504
- The efficacy and safety of memantine for the treatment of Alzheimer's disease.Expert Opin Drug Saf. 2018; 17: 1053-1061
- Switching cholinesterase inhibitors in older adults with dementia.Int Psychogeriatr. 2011; 23: 372-378
- AD2000 Collaborative Group. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.Lancet. 2004; 363: 2105-2115
- Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer’s Disease (DOMINO-AD) trial: secondary and post hoc analyses.Lancet Neurol. 2015; 14: 1171-1181
- Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia.Alzheimer's Dement. 2020; 16: 1182-1195
- A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease.Alzheimers Res Ther. 2017; 9: 95
- Trial of solanezumab for mild dementia due to Alzheimer's disease.N Engl J Med. 2018; 378: 321-330
- A resurrection of aducanumab for Alzheimer's disease.Lancet Neurol. 2020; 19: 111-112
- Treating Alzheimer’s disease with monoclonal antibodies: current status and outlook for the future.Alz Res Ther. 2013; 5: 56
- AD and its comorbidities: an obstacle to develop a clinically efficient treatment?.Rev Neurol (Paris). 2022; (S0035-3787(22)00546-X)https://doi.org/10.1016/j.neurol.2022.03.001
- Medicare’s decision not to fund Aduhelm changes the landscape for US pharma industry.BMJ. 2022; : 377https://doi.org/10.1136/bmj.o996
- Critical Appraisal of amyloid Lowering agents in AD.Curr Neurol Neurosci Rep. 2021; 21: 39
- Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.Cochrane Database Syst Rev. 2021; 2: CD013306
- Comparative efficacy and safety of cognitive enhancers for treating vascular cognitive impairment: systematic review and Bayesian network meta-analysis.Neural Regen Res. 2019; 14: 805-816
- Canadian Consensus Conference on diagnosis and treatment of dementia (CCCDTD)5: guidelines for management of vascular cognitive impairment.Alzheimer's Dementia (New York, N Y.). 2020; 6: e12056
- Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline.Neurology. 2020; 95: e320-e331
- Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial.Lancet Neurol. 2008; 7: 41-49
- Aspirin in Alzheimer’s disease: increased risk of intracerebral hemorrhage: cause for concern?.Stroke. 2010; 41: 2690-2692
- Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart association/American stroke association.Stroke. 2014; 45: 3754-3832
- Cognitive reserve in dementia: Implications for cognitive training.Front Aging Neurosci. 2016; 8https://doi.org/10.3389/fnagi.2016.00084
- Past, present, and future of non-invasive brain stimulation approaches to Treat cognitive impairment in neurodegenerative diseases: time for a Comprehensive Critical review.Front Aging Neurosci. 2021; 12: 578339
- Far transfer in cognitive training of older adults.Restorative Neurol Neurosci. 2009; 27: 455-471
- Cognitive training for people with mild to moderate dementia.Cochrane Database Syst Rev. 2019; (CD013069)
- Computerized cognitive training in older adults with mild cognitive impairment or dementia: a systematic review and meta-analysis.Am J Psychiatry. 2017; 174: 329-340
- Neuropsychiatric symptoms in dementia: considerations for Pharmacotherapy in the USA.Drugs R D. 2019; 19: 93-115
- Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the cardiovascular health study.JAMA. 2002; 288: 1475-1483
- Mild behavioral impairment and Subjective cognitive decline predict cognitive and functional decline.J Alzheimers Dis. 2021; 80: 459-469
- The consequences of non-cognitive symptoms of dementia in medical hospital departments.Int J Psychiatry Med. 2003; 33: 257-271
- American Geriatrics society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate medication Use in older adults.J Am Geriatr Soc. 2019; 67: 674-694
- Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.JAMA. 2005; 294: 1934-1943
- Wandering and dementia.Psychogeriatrics. 2014; 14: 135-142
- What do we know about strategies to manage dementia-related wandering? A scoping review.Alzheimers Demen. 2018; 10: 615-628
- Gait and cognition: a complementary approach to understanding brain function and the risk of falling.J Am Geriatr Soc. 2012; 60: 2127-2136
- Review of Gait, cognition, and fall risks with Implications for fall prevention in older adults with dementia.Dement Geriatr Cogn Disord. 2019; 48: 17-29
- Fall prevention in community-dwelling adults with mild to moderate cognitive impairment: a systematic review and meta-analysis.BMC Geriatr. 2021; 21: 689
- Multifactorial falls prevention programmes for older adults presenting to the emergency department with a fall: systematic review and meta-analysis.Inj Prev. 2019; 25: 557-564
- New horizons in falls prevention.Age Ageing. 2018; 47: 492-498
- Driving and dementia: efficient approach to driving safety concerns in family practice.Can Fam Physician. 2017; 63: 27-31
- Driving and dementia.BMJ. 2007; 334: 1365-1369
- Driving with a neurodegenerative disorder: an overview of the current literature.J Neurol. 2017; 264: 1678-1696
- Driving and Alzheimer's dementia or mild cognitive impairment: a systematic review of the existing guidelines emphasizing on the neurologist's role.Neurol Sci. 2021; 42: 4953-4963
- Firearm access and dementia: a qualitative study of reported behavioral disturbances and responses.J Am Geriatr Soc. 2022; 70: 439-448
- Biting the Bullet: firearm ownership in persons with dementia. A Registry-based Observational study.J Alzheimers Dis. 2021; 81: 179-188
- Is there a gun in the home?" Assessing the risks of gun ownership in older adults.J Am Geriatr Soc. 2014; 62: 1142-1146
- Factors associated with having a will, power of attorney, and advanced healthcare Directive in patients presenting to a Rural and Remote memory clinic.Can J Neurol Sci. 2019; 46: 319-330
- Perspectives of people with dementia and carers on advance care planning and end-of-life care: a systematic review and thematic synthesis of qualitative studies.Palliat Med. 2019; 33: 274-290
- Person-centered dementia care: current perspectives.Clin Interv Aging. 2016; 11: 1733-1740
- Advance care planning for people living with dementia: an umbrella review of effectiveness and experiences.Int J Nurs Stud. 2020; 107: 103576
- Dementia caregiver Burden: a research update and Critical analysis.Curr Psychiatry Rep. 2017; 19: 64
- Caregiver support groups in patients with dementia: a meta-analysis.Int J Geriatr Psychiatry. 2011; 26: 1089-1098
- The influence of day care centres designed for people with dementia on family caregivers - a qualitative study.BMC Geriatr. 2017; 17: 5
- Speech-language pathologist interventions for Communication in moderate-severe dementia: a systematic review.Am J Speech Lang Pathol. 2018; 27: 836-852
- Occupational therapy for people with dementia and their family carers provided at home: a systematic review and meta-analysis.BMJ Open. 2019; 9: e026308
- Physiotherapy intervention in Alzheimer's disease: systematic review and meta-analysis.J Alzheimers Dis. 2015; 44: 163-174
Article info
Publication history
Published online: October 18, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
